What We're Working On
Sequencing Solutions for Today and Tomorrow
Roche is committed to DNA sequencing, long term. We are investing in:
Significant performance and ease-of-use improvements to 454 GS Junior and GS FLX+ Systems.
An expanding menu of amplicon assays and SeqCap EZ panels for translational research applications.
Innovative technologies that will enable the next leap in performance, cost, and scalability for the future of sequencing.
GS Junior System
Going to great lengths + workflow automation = powerful benchtop sequencing
Read length extension beyond 400 bp will deliver more Sanger-like reads
Automation solutions will reduce hands-on time and drive lab efficiency
GS FLX+ System
Dependability and long amplicon sequencing
Software upgrade, hardware adjustments, and self-test capabilities will drive improved GS FLX+ System robustness
Extra-long read amplicon sequencing with the GS FLX+ Instrument and XL+ Sequencing Kits will be introduced
Expanding the application menu
New sequence-based assays for infectious disease (HIV, HBV, HCV drug resistance). *Available only in select countries.
GS GType TET2/CBL/KRAS & RUNX1 Primer Sets for leukemia research
GS GType HLA MR & HR Primer Sets for human leukocyte antigen typing research
Effective target enrichment for customized content
Apply our proven capture technology to your custom research using SeqCap EZ Choice and new SeqCap EZ Developer Libraries
Discover more and sequence less for your specific application areas